Zdrowie i gospodarka · 13/04/1999
FDA to Revoke Guidance Texts for Progestational Drug Products
The FDA is revoking previously issued guidance texts for progestational drug products, citing reasons discussed in a notice of proposed rulemaking, following previously issued guidance texts published in the Federal Register on January 12, 1989.
Source: Federal Register — Food and Drug AdministrationOpen original release →